FIGURE 6.

Multi-Omics Model integrating histopathological image features with omics data. (A) The time-dependent receiver operating characteristic curve, and (B) Kaplan-Meier curves for multi-omics model involving image features, genomics, transcriptomics, and proteomics in validation set. (C) Decision curve analysis for each model in validation set. The gray oblique line represented net benefit of intervening all patients, and horizontal gray line meant that net benefit of no patients with intervention. The multi-omics had the highest net benefit compared with other models across the range of >10% in risk threshold.